Atrial fibrosis and the mechanisms of atrial fibrillation - Wikidata - awgldk - TriplyDB

Atrial fibrosis and the mechanisms of atrial fibrillation

Atrial fibrosis and the mechanisms of atrial fibrillation

http://www.wikidata.org/entity/Q34576855

about

MURC, a muscle-restricted coiled-coil protein that modulates the Rho/ROCK pathway, induces cardiac dysfunction and conduction disturbance Managing atrial fibrillation in the very elderly patient: challenges and solutions Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate Triggers and anatomical substrates in the genesis and perpetuation of atrial fibrillation Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation Nonequilibrium arrhythmic states and transitions in a mathematical model for diffuse fibrosis in human cardiac tissue The fibrosis-cell death axis in heart failure Analysis on differential gene expression data for prediction of new biological features in permanent atrial fibrillation.Galectin 3 and incident atrial fibrillation in the community.Evaluation of the Pulmonary Veins and Left Atrial Volume using Multidetector Computed Tomography in Patients Undergoing Catheter Ablation for Atrial Fibrillation.Pitx2, an atrial fibrillation predisposition gene, directly regulates ion transport and intercalated disc genes.Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation.Atrial fibrillation in congestive heart failure.TRPM7-mediated Ca2+ signals confer fibrogenesis in human atrial fibrillation.Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing.Establishment of a model of renal impairment with mild renal insufficiency associated with atrial fibrillation in canines.Obesity and atrial fibrillation.The expression levels of plasma micoRNAs in atrial fibrillation patients.Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7.Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-β1.Protein analysis of atrial fibrosis via label-free proteomics in chronic atrial fibrillation patients with mitral valve disease.Drosophila as a model to study cardiac aging Prolonged PR interval predicts clinical recurrence of atrial fibrillation after catheter ablation.Renal denervation suppresses atrial fibrillation in a model of renal impairment.GATA6 reporter gene reveals myocardial phenotypic heterogeneity that is related to variations in gap junction coupling.Atrial fibrillation and heart failure parallels: lessons for atrial fibrillation prevention.Loading effect of fibroblast-myocyte coupling on resting potential, impulse propagation, and repolarization: insights from a microstructure model.Prevention of postoperative atrial fibrillation: novel and safe strategy based on the modulation of the antioxidant system NOX4-Dependent Hydrogen Peroxide Overproduction in Human Atrial Fibrillation and HL-1 Atrial Cells: Relationship to Hypertension.Association of Plasma Transforming Growth Factor-β1 Levels and the Risk of Atrial Fibrillation: A Meta-Analysis Ablation of sarcolipin results in atrial remodeling Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study.The Use of Gene Therapy for Ablation of Atrial Fibrillation.Is there a role for remodeled connexins in AF? No simple answers.Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction.Accelerated fibrosis and apoptosis with ageing and in atrial fibrillation: Adaptive responses with maladaptive consequences.Autonomic remodeling in the left atrium and pulmonary veins in heart failure: creation of a dynamic substrate for atrial fibrillation.Spironolactone therapy is associated with reduced ventricular tachycardia rate in patients with cardiomyopathy Effects of Angiotensin-II Receptor Blocker on Inhibition of Thrombogenicity in a Canine Atrial Fibrillation Model.Diminished cardiac fibrosis in heart failure is associated with altered ventricular arrhythmia phenotype.

P2860

Q24309495-74FC3A19-C63C-4330-8281-F07D7DF532C5 Q26775877-86E0B1DE-8587-4E08-A24C-9A1165656E69 Q26799163-E7ED8C16-DDBF-448E-82EA-E36C98AE104E Q26858987-AA0DD6E1-5A88-4E59-9A15-3E80FEBF3672 Q26864767-7EED21C4-510B-4B5B-961D-72EDD3A7AB3A Q27318715-6998123C-53D1-4F46-BEA0-8D9932596C3D Q28076570-7DD73CAE-E524-4919-AE5C-15C470EAC20B Q30690800-B008DAEC-3DFE-473D-BE51-D45616618EC0 Q33555143-7840D1E4-63C4-4F3C-9C61-9862EF2D3BAD Q33578025-87F1B863-92DC-416D-8556-1A150B707C69 Q33580059-E19CE024-D254-4170-80B9-636838BFB610 Q33631107-DE523A7D-AC7B-4C86-B504-E10E2A245A39 Q33954432-16DDF9F4-E637-4A4C-91EF-E9F15C26CAD0 Q34008101-8ABF4B72-2D15-497E-ABD8-B00E87FBD140 Q34078738-FA029494-9FA0-4036-B34E-D01AE5228D26 Q34090205-8D6DB398-2071-476A-873B-06C9DDE7103C Q34359362-4CD127D3-041C-49DC-AFBE-347EDA1DC57E Q34427635-AB958C8C-85C8-4181-BE89-9C1A33811A85 Q34559487-B9A749E3-57C2-4FCE-B68C-540D0AF757DB Q34650822-D0598DC4-D3ED-466E-A50D-89180B693B39 Q34672752-0DD572CF-6185-42CB-8DCF-6310EBC6845C Q34819187-EEDF60F9-2CBD-4886-8E62-840F66084628 Q35070600-03D09D36-2B18-4B49-B5A2-1465E2A8C8B1 Q35464440-27376DEB-5352-457A-8CF4-DFE6A1D66C8C Q35543454-347DE76C-E23D-40AA-AEDC-4CDF7C56DD37 Q35563922-D7587FAB-9553-4766-A3F9-0AC21051D532 Q35799646-7EA5019D-2A6F-446D-BA5E-D9A2B5374480 Q35885268-7B1C46A7-025E-40A9-A851-F81E77C04FE4 Q36008536-81BC5748-31D3-4E10-9DC2-1CD8A90EA033 Q36015700-251CFF6C-797F-4EF2-9B4F-65C37BF2598A Q36041897-B96135BC-6809-4D47-B194-D108AEF773A0 Q36421870-B4BBFEFF-1D6F-4ED8-922C-B174E03FF2C6 Q36458906-EEDAC9DB-5D2F-4F71-BC05-4220DD346DF9 Q36459867-5EEA0788-1DED-4635-87B5-6C60ABF1A161 Q36535510-CB60DF9A-ADFF-441C-9499-DCD55FADA665 Q36603719-F0718BBE-3953-4F1B-814A-F8C0EA7034B9 Q36713726-BA221E98-DDA7-4009-8CC4-271D0D6857A5 Q36742973-F20DD43A-A9B5-445C-ACD0-FD5ED40B417A Q36964621-02233B42-0E6C-4C18-B9DC-F8366B938564 Q36988687-2F8965CF-0872-4A5F-BCB9-BC4B412A678D

P2860

Atrial fibrosis and the mechanisms of atrial fibrillation

http://www.wikidata.org/entity/Q34576855

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Atrial fibrosis and the mechanisms of atrial fibrillation

@ast

Atrial fibrosis and the mechanisms of atrial fibrillation

@en

Atrial fibrosis and the mechanisms of atrial fibrillation

@nl

type

label

Atrial fibrosis and the mechanisms of atrial fibrillation

@ast

Atrial fibrosis and the mechanisms of atrial fibrillation

@en

Atrial fibrosis and the mechanisms of atrial fibrillation

@nl

prefLabel

Atrial fibrosis and the mechanisms of atrial fibrillation

@ast

Atrial fibrosis and the mechanisms of atrial fibrillation

@en

Atrial fibrosis and the mechanisms of atrial fibrillation

@nl

P1433

Q34576855-1FFACCD5-ABBC-4256-9581-0C82BF438E4F

P1476

Q34576855-713AB13C-5227-4BCF-8A54-2DD6A56F52F4

P2093

Q34576855-5ECBF43D-2224-4D55-A5AD-A1ABCB83B3FB

Q34576855-EEB42694-4A6F-41E9-A68C-327CD3A22349

P2860

Q34576855-00610CA2-A176-4187-9354-AC033EEB5C88

Q34576855-062EB773-05EA-42D8-B4F9-D5F3E9A301EE

Q34576855-133BC1C8-D741-4D3B-AB4A-0A29327939FE

Q34576855-1A3B58A3-18BF-4454-8514-8CA5A04AE213

Q34576855-22167514-2CD3-44D3-A2E6-1E85113C621C

Q34576855-2FD1A323-D98C-4996-9509-D95501F8F009

Q34576855-32976572-BB77-4DB4-BC23-A73F7103E014

Q34576855-32EFE179-ADD2-4FAD-9CB1-D2900B585EA2

Q34576855-39AE0EA1-B612-44CC-9082-F2E9AA789F51

Q34576855-42686E09-00A4-4A34-A69E-B0A671FEB057

P304

Q34576855-9A9C56D1-A5ED-403B-9630-CFDE70E0B9BA

P31

Q34576855-9CF74F92-A2DF-4C62-B595-6468ED465D2E

P356

Q34576855-137B44FC-4708-470D-B6F9-EE56D7BE92A1

P433

Q34576855-A5D8784E-8259-4F36-956C-130651991F06

P478

Q34576855-330CCBB1-3400-4159-8CC5-8BBB641DE871

P577

Q34576855-15FC0BB7-7E35-4AE1-B95F-6DC5AD71C53A

P5875

Q34576855-6477711A-4B64-48BB-8B7A-85D75242722D

P698

Q34576855-C78676AE-81C2-4952-ABAA-5179DF22793F

P921

Q34576855-EE7A2405-1CA9-4989-B109-C942F8B034FC

P932

Q34576855-59C3EB87-A6D1-4F25-9F6B-2D6D46739047

P356

J.HRTHM.2006.12.040

P1433

P1476

Atrial fibrosis and the mechanisms of atrial fibrillation

@en

P2093

Jeffrey E Olgin

http://www.w3.org/2001/XMLSchema#string

Thomas H Everett

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart

Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure

Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins

Induction of cardiac fibrosis by transforming growth factor-beta(1).

Pirfenidone effectively reverses experimental liver fibrosis.

Inflammation as a risk factor for atrial fibrillation.

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.

Histological substrate of atrial biopsies in patients with lone atrial fibrillation.

Pirfenidone improves renal function and fibrosis in the post-obstructed kidney.

P304

S24-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.HRTHM.2006.12.040

http://www.w3.org/2001/XMLSchema#string

P433

3 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6469665

http://www.w3.org/2001/XMLSchema#string

P698

17336879

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation

P932

1850572

http://www.w3.org/2001/XMLSchema#string